RxDoctor Payments Data

Teresa Johnson, MD

Family Medicine · Idaho Falls, IDNPI 1285642322

Payments from drug & device makers

$2,566in general payments, 2019–2025

Across 148 payments — averaging $17.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$911
  • Pfizer$263
  • Novo Nordisk$201
  • Amgen$146
  • Nestle Healthcare Nutrition Inc.$143
  • Lilly USA, LLC$110
  • plus $791 from 23 others

What the payments were for

  • Food & beverage$2,46596%
  • Education$1014%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,566 in reported general payments places this provider in the 85th percentile of 803 family medicine providers in Idaho.

See all family medicine providers in Idaho

Medicare billing

Part B allowed, 2024
$70,551
Medicare patients
217
Services billed
1,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Avonex (4 Pack)Interferon Beta-1a13$102,902
EliquisApixaban96$91,389
OzempicSemaglutide34$37,963
JardianceEmpagliflozin26$25,474
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$18,441
MounjaroTirzepatide16$16,476
LinzessLinaclotide17$15,283
JanuviaSitagliptin Phosphate12$11,367
Solifenacin Succinate24$9,387
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$9,269
Celecoxib87$8,365
Spiriva RespimatTiotropium Bromide17$8,143
Combivent RespimatIpratropium/Albuterol Sulfate12$5,973
Morphine Sulfate ErMorphine Sulfate13$5,735
VascepaIcosapent Ethyl16$5,339

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$263$92,818110 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat$91$39,59155 claims
Novo NordiskOzempic$201$37,96334 claims
GSKTrelegy Ellipta$18$18,44121 claims
Lilly USA, LLCMounjaro$110$16,47616 claims
AbbVieLinzess$911$15,28317 claims
MerckJanuvia$28$11,36712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 803 family medicine providers in Idaho.

Other family medicine in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →